RedHill Biopharma | RDHL - Operating Profit

Stock Price
0.87
Daily Change
-0.01 -1.14%
Monthly
-14.71%
Yearly
-66.02%
Q1 Forecast
0.84

RedHill Biopharma reported $-4.22M in Operating Profit for its fiscal quarter ending in June of 2024.





Operating Profit Change Date
Cara Therapeutics USD -2.39M 3.49M Mar/2025
Clal Biotechnology ILS -1.74M 7.46M Dec/2022
Compugen USD -7.89M 540K Sep/2025
Cronos Group USD -7.06M 62.31M Dec/2025
RedHill Biopharma USD -4.22M 1.8M Jun/2024